CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

BACKGROUND: Locally advanced breast cancer often undergoes neoadjuvant chemotherapy (NAC), which allows in vivo evaluation of the therapeutic response. The determination of the pathological complete response (pCR) is one way to evaluate the response to neoadjuvant chemotherapy. However, the rate of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Alves, Wilson Eduardo Furlan Matos, Bonatelli, Murilo, Dufloth, Rozany, Kerr, Lígia Maria, Carrara, Guilherme Freire Angotti, da Costa, Ricardo Filipe Alves, Scapulatempo-Neto, Cristovam, Tiezzi, Daniel, da Costa Vieira, René Aloísio, Pinheiro, Céline
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889185/
https://ncbi.nlm.nih.gov/pubmed/31795962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6353-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados